Skip to main content

Table 3 Gastrointestinal comorbidities, symptoms and investigative procedures among CRC cases and non-cases in 2002 and 2014

From: Trends in the contemporary incidence of colorectal cancer and patient characteristics in the United Kingdom: a population-based cohort study using The Health Improvement Network

 

CRC cases

 

p-value

Non-cases

 

p-value

2002 (N = 921)

2014 (N = 1330)

% change

 

2002 (N = 1,125,723)

2014 (N = 1,756,868)

% change

 

n (%)

n (%)

n (%)

n (%)

Bleeding per rectum

79 (8.6)

73 (5.5)

− 3.1

0.004

22,989 (2.0)

38,394 (2.2)

+ 0.2

< 0.001

Change in bowel habits

26 (2.8)

54 (4.1)

+ 1.3

0.119

12,190 (1.1)

29,360 (1.7)

+ 0.6

< 0.001

Abnormal weight loss

19 (2.1)

26 (2.0)

−0.1

0.857

7972 (0.7)

20,924 (1.2)

+ 0.5

< 0.001

GI adenoma

20 (2.2)

41 (3.1)

+ 0.9

0.191

5035 (0.4)

16,565 (0.9)

+ 0.5

< 0.001

GORD

48 (5.2)

88 (6.6)

+ 1.4

0.169

55,237 (4.9)

110,752 (6.3)

+ 1.4

< 0.001

Complicated/uncomplicated PU

20 (2.2)

28 (2.1)

−0.1

0.915

13,891 (1.2)

13,544 (0.8)

−0.4

< 0.001

Complicated PU

9 (1.0)

23 (1.7)

+ 0.7

0.138

6994 (0.6)

9015 (0.5)

−0.1

< 0.001

Uncomplicated PU

13 (1.4)

8 (0.6)

−0.8

0.049

7977 (0.7)

5484 (0.3)

−0.4

< 0.001

IBD

19 (2.1)

25 (1.9)

−0.2

0.700

26,919 (2.4)

33,242 (1.9)

−0.5

0.032

National bowel screening programme

34 (3.7)

190 (14.3)

+ 10.6

< 0.001

< 0.001

187,548 (10.7)

+ 9.7

< 0.001

Colonoscopy

26 (2.8)

83 (6.2)

+ 3.4

< 0.001

17,952 (1.6)

73,186 (4.2)

+ 2.6

< 0.001

Sigmoidoscopy

44 (4.8)

54 (4.1)

−0.7

0.412

19,980 (1.8)

36,673 (2.1)

+ 0.3

< 0.001

Barium enema

95 (10.3)

14 (1.1)

−9.2

< 0.001

45,149 (4.0)

9619 (0.5)

−3.5

< 0.001

  1. CRC colorectal cancer, GI gastrointestinal, GORD gastro-oesophageal reflux disease, IBD irritable bowel disease, PU peptic ulcer